Summary of Classification and Labelling
Notified classification and labelling
General Information
603-837-5 |
(2-allyloxy-1,1-dimethyl-2-oxo-ethyl) 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidin-1-yl]benzoate |
134605-64-4 |
Notified classification and labelling according to CLP criteria
Aquatic Acute 1 |
H400
|
H400
|
|
GHS09 Wng
|
|
|
|
|
38 |
|
View details
|
STOT RE 2 |
H373
(other:Liver)
(oral)
|
H373
(May cause damag...)
|
|
GHS08 GHS09 Wng
|
M=1000 M(Chronic)=1000
|
|
|
|
28 |
|
View details
|
Aquatic Acute 1 |
H400
|
|
Aquatic Chronic 1 |
H410
|
H410
|
Number of Aggregated Notifications: 2